Virios Fibromyalgia Drug Fails Phase IIb And Firm Says COVID-19 May Be To Blame

thumb up and down
Virios saw different results in different cohorts in Phase IIb • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D